San-Miguel, J. F., & Goldschmidt, H. (2015). Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma. Haematologica, 100(10), . https://doi.org/10.3324/haematol.2015.125864
Chicago Style (17th ed.) CitationSan-Miguel, Jesús F., and Hartmut Goldschmidt. "Impact of Prior Treatment and Depth of Response on Survival in MM-003, a Randomized Phase 3 Study Comparing Pomalidomide Plus Low-dose Dexamethasone Versus High-dose Dexamethasone in Relapsed/refractory Multiple Myeloma." Haematologica 100, no. 10 (2015). https://doi.org/10.3324/haematol.2015.125864.
MLA (9th ed.) CitationSan-Miguel, Jesús F., and Hartmut Goldschmidt. "Impact of Prior Treatment and Depth of Response on Survival in MM-003, a Randomized Phase 3 Study Comparing Pomalidomide Plus Low-dose Dexamethasone Versus High-dose Dexamethasone in Relapsed/refractory Multiple Myeloma." Haematologica, vol. 100, no. 10, 2015, https://doi.org/10.3324/haematol.2015.125864.